KN

Kashyap Navinchandra Dabhi

Active Director Designated Partner DIN 11550819
DIN 11550819 First appointment Feb 2026
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Feb 2026
Shareholding value β€’β€’β€’β€’ Premium profile

About Kashyap Navinchandra Dabhi

Data last updated:

Kashyap Navinchandra Dabhi is a Designated Partner at Accupath Histopathology & Molecular Laboratory Llp (since 2026).

DIN 11550819
Primary Designation Designated Partner
First Appointment 17 Feb 2026

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Designated Partner17 Feb 20262026Active

Board colleagues of Kashyap Navinchandra Dabhi

NameDINCompanyDesignation
Rajanikant Khodabhai Patel10380895Accupath Histopathology & Molecular Laboratory LlpDesignated Partner

Directorship timeline

Open interactive timeline →
Accupath Histopathology & Molecular Laboratory Llp
Premium access

Shareholding and investment profile for Kashyap Navinchandra Dabhi

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Kashyap Navinchandra Dabhi

Kashyap Navinchandra Dabhi currently holds 1 directorship: Accupath Histopathology & Molecular Laboratory Llp (Designated Partner, since 17 Feb 2026).

Kashyap Navinchandra Dabhi was first appointed on 17 Feb 2026 as Designated Partner at Accupath Histopathology & Molecular Laboratory Llp.

The current boards of Kashyap Navinchandra Dabhi's companies include Rajanikant Khodabhai Patel (Accupath Histopathology & Molecular Laboratory Llp).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available